Rating
Hold
Price target
$375
Previous
Implied upside
+11%

UBS analyst Stephen Ju reiterated a Neutral rating and $375.00 price target on Alphabet (NASDAQ: GOOGL).

“In our view this year’s Cloud Next announcements should serve as another marker to drive investor confidence around the persistent ROIC questions around Google’s GenAI CapEx.

We liked signs that enterprise adoption of Gemini and related products continue to ramp (40% 4Q25 to 1Q26 growth of Enterprise MAUs), as well as practical demonstrations from client companies using various products.

Both of these should be positive signals to get more comfortable underwriting multiyear CapEx cycles and further prove that demand is not just Anthropic and OpenAI.

A year ago, investors were questioning whether Google was lagging on GenAI productization – and this event shows that Google has caught up, with new releases focused on early adopter requirements, next gen TPUs with better price performance, and new use cases like Agent Platform.

That said, we believe much of this benefit is already priced in to the stock in the form of accelerating revenue growth for 1Q26 as well as the historically high multiple.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.